GZ6G Technologies Corp.
A financially distressed OTC technology firm facing severe liquidity constraints and massive operating losses with no disclosed revenue streams.
A financially distressed OTC technology firm facing severe liquidity constraints and massive operating losses with no disclosed revenue streams.
Investors might consider GZIC only for high-risk speculative plays betting on a sudden turnaround, acquisition by a larger entity, or asset restructuring that could wipe out liabilities. Any positive news regarding new contracts or government grants could theoretically reset the stock price from its distressed levels. The low market cap provides an entry point for those willing to endure extreme volatility and potential total loss.
The company is fundamentally insolvent with liabilities of $10.1M exceeding assets of $1.4M, making equity value negligible in a liquidation scenario. There is no evidence of revenue generation or operational improvement, as net income remains at -$6.9M year-over-year. Capital structure is fragile, relying on dilutive share issuances and high interest expenses that threaten to deplete remaining cash entirely.
GZ6G Technologies Corp. (GZIC) is an OTC-traded entity reporting significant net losses of $6.9M against minimal revenue of $0.2M in 2022, with substantial liabilities exceeding assets. The company operates within a high-risk financial landscape characterized by deep retained earnings deficits and aggressive financing activities. Detailed segment data is not available in the provided filings, indicating a potential lack of diversified business operations or undisclosed restructuring.
Management appears to be prioritizing capital preservation through financing activities, evidenced by a net change in cash of -$252k and reliance on external funding. Operating profit remains deeply negative at -$3.5M, while interest expense of $7.1M significantly erodes the already thin profit margins. The company is burning through its remaining cash reserves without visible paths to profitability or revenue growth.
The OTC technology sector often hosts early-stage or distressed firms where transparency varies significantly compared to major exchanges. Companies in this space frequently struggle with liquidity constraints and may lack the robust financial controls seen in publicly traded peers on national exchanges. Investors must exercise extreme caution as many entities in this category face delisting risks due to non-compliance or financial distress.
| Metric | 2022 |
|---|---|
| Revenue | $221.9K |
| Cost of Revenue | $18.3K |
| Gross Profit | $203.7K |
| Operating Expenses | $3.7M |
| Operating Income | $-3.5M |
| G&A | $3.0M |
| Depreciation | $125.4K |
| Other OpEx | $719.2K |
| Non-Operating Income | $18.3K |
| Interest Expense | $7.1M |
| Pre-Tax Income | $-3.5M |
| Income Tax | $3.5M |
| Continuing Ops | $-6.9M |
| Discontinued Ops | $0 |
| Net Income | $-6.9M |
| Minority Interest | $-56.2K |
| Net to Common | $-6.9M |
| Metric | 2022 |
|---|---|
| Current Assets | $632.1K |
| Accounts Receivable | $59.8K |
| Other Current Assets | $572.3K |
| Long-Term Assets | $740.6K |
| PP&E (Net) | $187.7K |
| Other LT Assets | $553.0K |
| Total Assets | $1.4M |
| Current Liabilities | $9.5M |
| Current Leases | $91.6K |
| Other Current Liab | $9.4M |
| Long-Term Liabilities | $526.3K |
| Long-Term Debt | $44.0K |
| LT Operating Leases | $482.3K |
| Other LT Liab | $0 |
| Total Liabilities | $10.1M |
| Shareholders' Equity | $-8.7M |
| Paid-In Capital | $14.9M |
| Retained Earnings | $-23.0M |
| Total L&E | $1.4M |
| Metric | 2022 |
|---|---|
| Net Income (CFO) | $-6.9M |
| Non-Cash Adjustments | $4.1M |
| Working Capital Changes | $360.7K |
| Cash from Operations | $-2.5M |
| Capital Expenditures | $107.9K |
| Cash from Investing | $-77.9K |
| Cash from Financing | $2.3M |
| FX Effect | $0 |
| Net Change in Cash | $-252.6K |
| Beginning Cash | $759.8K |
| Ending Cash | $507.2K |
The company's financials suggest a single, highly volatile revenue stream as total revenue is negligible compared to expenses. There are no clearly defined operational segments based on the provided data, which shows a net profit deficit and significant other non-operating income/loss adjustments that obscure traditional segment reporting.
Severe liquidity crisis with cash flow from operations at -$2.5M and a retained earnings deficit of -$23.0M. Solvency risk is high given current liabilities of $9.5M against total assets of only $1.4M. The company relies heavily on equity issuance ($151k common shares) to fund operations rather than organic cash generation.
None identified in the current financial state; the company faces immediate survival challenges rather than established market moats. The primary 'advantage' is currently the lack of public scrutiny required for larger, profitable competitors, allowing it to remain on OTC markets despite insolvency indicators.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.